Advanced search
1 file | 6.10 MB

New options for molecular therapy of neuroblastoma: from p53 to gene therapy

Tom Van Maerken (UGent)
(2011)
Author
Promoter
(UGent) and (UGent)
Organization
Keywords
gene therapy, MDM2, molecular therapy, hPNPase, nutlin-3, Neuroblastoma, p53

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 6.10 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Van Maerken, Tom. 2011. “New Options for Molecular Therapy of Neuroblastoma: From P53 to Gene Therapy”. Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
APA
Van Maerken, T. (2011). New options for molecular therapy of neuroblastoma: from p53 to gene therapy. Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium.
Vancouver
1.
Van Maerken T. New options for molecular therapy of neuroblastoma: from p53 to gene therapy. [Ghent, Belgium]: Ghent University. Faculty of Medicine and Health Sciences; 2011.
MLA
Van Maerken, Tom. “New Options for Molecular Therapy of Neuroblastoma: From P53 to Gene Therapy.” 2011 : n. pag. Print.
@phdthesis{1150297,
  author       = {Van Maerken, Tom},
  isbn         = {9789490695484},
  keyword      = {gene therapy,MDM2,molecular therapy,hPNPase,nutlin-3,Neuroblastoma,p53},
  language     = {eng},
  pages        = {188},
  publisher    = {Ghent University. Faculty of Medicine and Health Sciences},
  school       = {Ghent University},
  title        = {New options for molecular therapy of neuroblastoma: from p53 to gene therapy},
  year         = {2011},
}